Melanoma Induces Immunosuppression by Up-Regulating FOXP3+ Regulatory T Cells
- 1 July 2007
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 141 (1) , 72-77
- https://doi.org/10.1016/j.jss.2007.03.053
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skinBlood, 2006
- The treatment of melanoma with an emphasis on immunotherapeutic strategiesSurgical Oncology, 2006
- FOXP3 Controls Regulatory T Cell Function through Cooperation with NFATCell, 2006
- Increased Prevalence of Regulatory T Cells (Treg) is Induced by Pancreas AdenocarcinomaJournal of Immunotherapy, 2006
- FOXP3: Of Mice and MenAnnual Review of Immunology, 2006
- Characterization of CD4+CD25+ Regulatory T Cells in Patients Treated With High-Dose Interleukin-2 for Metastatic Melanoma or Renal Cell CarcinomaJournal of Clinical Oncology, 2006
- CD4+CD25+ regulatory T cells in patients with gastrointestinal malignanciesCancer, 2003
- Foxp3 programs the development and function of CD4+CD25+ regulatory T cellsNature Immunology, 2003
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findingsJAMA, 1986